Filtered By:
Source: Journal of Stroke and Cerebrovascular Diseases
Condition: Hemorrhagic Stroke
This page shows you your search results in order of relevance. This is page number 14.
Order by Relevance | Date
Total 1025 results found since Jan 2013.
Asymptomatic Hemorrhagic Transformation after Acute Ischemic Stroke: Is It Clinically Innocuous?
Whether asymptomatic hemorrhagic transformation (HT) is clinically innocuous, that is, unassociated with clinically detectable neurologic deterioration, remains an open question. To explore this, we examined whether asymptomatic HT affects long-term poor outcome and risk of stroke recurrence.
Source: Journal of Stroke and Cerebrovascular Diseases - October 11, 2014 Category: Neurology Authors: Chunyan Lei, Bo Wu, Ming Liu, Yanchao Chen Source Type: research
Intra-arterial Administration of Papaverine during Mechanical Thrombectomy for Acute Ischemic Stroke
The use of stent retrievers for mechanical thrombectomy in acute ischemic stroke may induce significant vasospasm, which at the early phases of reperfusion may be crucial for rethrombosis of the recanalized vessel. We aimed to study whether the use of intra-arterial papaverine in selected cases of vasospasm was associated with improved cerebral perfusion, arterial reocclusion, or increased hemorrhagic complications.
Source: Journal of Stroke and Cerebrovascular Diseases - November 13, 2014 Category: Neurology Authors: Gerasimos Baltsavias, Susmitha Yella, Rahman Abdul Al Shameri, Andreas Luft, Anton Valavanis Source Type: research
Intravenous Thrombolysis with Recombinant Tissue-type Plasminogen Activator for Acute Ischemic Stroke in Patients with Metabolic Syndrome
The metabolic syndrome (MetS) is common in patients with acute ischemic stroke (IS); however, its impact on outcome after intravenous thrombolysis (iv-thrombolysis) remains unclear. Thus, we aimed at evaluating the relationship between MetS and functional long-term outcome, mortality, and the presence of hemorrhagic complications in patients with IS treated with iv-thrombolysis.
Source: Journal of Stroke and Cerebrovascular Diseases - May 7, 2015 Category: Neurology Authors: Piotr Sobolewski, Waldemar Brola, Wiktor Szczuchniak, Małgorzata Fudala, Grzegorz Kozera Source Type: research
Protocol for Cerebral Microbleeds During the Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients With Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial
Anticoagulants are widely used to prevent recurrence of ischemic stroke in patients with nonvalvular atrial fibrillation, but in some patients, they also cause bleeding, particularly intracranial hemorrhage. One of the independent predictors of intracerebral hemorrhage is the presence of cerebral microbleeds (CMBs); a high incidence of intracerebral hemorrhage is reported in warfarin-treated patients with multiple CMBs. Longitudinal study suggested that the presence of CMBs at baseline is a predictor of new CMBs in warfarin-treated patients.
Source: Journal of Stroke and Cerebrovascular Diseases - July 4, 2015 Category: Neurology Authors: Shunya Takizawa, Fumiaki Tanaka, Kazutoshi Nishiyama, Yasuhiro Hasegawa, Eiichiro Nagata, Atsushi Mizuma, Sachiko Yutani, Taira Nakayama, Hiroyuki Kobayashi, Noriharu Yanagimachi, Takashi Okazaki, Kazuo Kitagawa, CMB-NOW Study Investigators Source Type: research
Incidence and Predictors of Hemorrhagic Stroke in Users of Low-Dose Acetylsalicylic Acid
This study was performed to characterize the incidence and predictors of HS in users of acetylsalicylic acid (ASA) for the secondary prevention of cardiovascular events.
Source: Journal of Stroke and Cerebrovascular Diseases - July 15, 2015 Category: Neurology Authors: Antonio González-Pérez, María Eugenia Sáez, Saga Johansson, Anders Himmelmann, Luis A. García Rodríguez Source Type: research
Influence of Antiplatelet Drugs on the Outcome of Subarachnoid Hemorrhage Differs with Age
The aim of this study was to examine the risk factor profiles and functional outcomes of subarachnoid hemorrhage (SAH) in different age groups, focusing on the effect of antiplatelet drugs when used before stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - July 20, 2015 Category: Neurology Authors: Yuji Kato, Takeshi Hayashi, Norio Tanahashi, Shotai Kobayashi, the Japan Standard Stroke Registry Study Group Source Type: research
Resource Utilization for Patients with Intracerebral Hemorrhage Transferred to a Comprehensive Stroke Center
As a comprehensive stroke center (CSC), we accept transfer patients with intracerebral hemorrhage (ICH) in our region. CSC guidelines mandate receipt of patients with ICH for higher level of care. We determined resource utilization of patients accepted from outside hospitals compared with patients directly arriving to our center.
Source: Journal of Stroke and Cerebrovascular Diseases - October 9, 2015 Category: Neurology Authors: Claude Nguyen, Osman Mir, Farhaan Vahidy, Tzu-Ching Wu, Karen Albright, Amelia Boehme, Rigoberto Delgado, Sean Savitz Source Type: research
Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry
Prior ischemic stroke or transient ischemic attack (TIA) is a high risk for thromboembolism in patients with nonvalvular atrial fibrillation (NVAF). To clarify rates of thromboembolic and hemorrhagic events, and target intensities of warfarin for secondary prevention, a subanalysis was performed using data from the J-RHYTHM Registry.
Source: Journal of Stroke and Cerebrovascular Diseases - December 22, 2015 Category: Neurology Authors: Eitaro Kodani, Hirotsugu Atarashi, Hiroshi Inoue, Ken Okumura, Takeshi Yamashita, Hideki Origasa, J-RHYTHM Registry Investigators Source Type: research
Coexistence of Deep Vein Thrombosis, Heterotopic Ossification, and Complex Regional Pain Syndrome due to Hemorrhagic Stroke
A patient who developed hemiplegia related to a hemorrhagic stroke and who had not been started on venous thromboembolism prophylaxis or a physical medicine and rehabilitation program was admitted to our clinic on the 4th month after the event. Our patient had pain, swelling, redness, increased temperature at the right lower extremity, range of motion limitation at the hip and knee, deep vein thrombosis (DVT) and complex regional pain syndrome (CRPS) at the same side lower extremity, and heterotopic ossification (HO) at the hip.
Source: Journal of Stroke and Cerebrovascular Diseases - January 8, 2016 Category: Neurology Authors: Engin Koyuncu, Güldal Funda Nakipoğlu Yüzer, Didem Yenigün, Neşe Özgirgin Tags: Case Studies Source Type: research
Cerebral Microbleeds Meta-analyses of Prospective Studies: The Need to Consider Both Ischemic and Hemorrhagic Stroke Outcomes
I read with interest the recent meta-analysis by Wang et al,1 reporting a high risk of intracerebral hemorrhage (ICH) in ischemic stroke/transient ischemic attack patients with cerebral microbleeds—especially those with multiple lesions or taking aspirin. The paper largely corroborates findings of a previous meta-analysis on the topic,2 but also presents some clinically relevant new observations. A key new result is that the presence of a single microbleed (compared to no microbleeds) does not seem to significantly increase the risk of future ICH in this patient population (relative risk: 2.33, 95% confidence interval: ...
Source: Journal of Stroke and Cerebrovascular Diseases - January 13, 2016 Category: Neurology Authors: Andreas Charidimou Tags: Letter to the Editor Source Type: research
Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial
More than 50% of patients with acute intracerebral hemorrhage (ICH) are taking antihypertensive drugs before ictus. Although antihypertensive therapy should be given long term for secondary prevention, whether to continue or stop such treatment during the acute phase of ICH remains unclear, a question that was addressed in the Efficacy of Nitric Oxide in Stroke (ENOS) trial.
Source: Journal of Stroke and Cerebrovascular Diseases - February 4, 2016 Category: Neurology Authors: Kailash Krishnan, Polly Scutt, Lisa Woodhouse, Alessandro Adami, Jennifer L. Becker, Lesley A. Cala, Ana M. Casado, Christopher Chen, Robert A. Dineen, John Gommans, Panos Koumellis, Hanna Christensen, Ronan Collins, Anna Czlonkowska, Kennedy R. Lees, Geo Source Type: research
A Four-Year Experience of Symptomatic Intracranial Hemorrhage Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center
To describe the 4-year experience of symptomatic intracranial hemorrhage (sICH) rate at a high-volume comprehensive stroke center.
Source: Journal of Stroke and Cerebrovascular Diseases - February 5, 2016 Category: Neurology Authors: Alessandro Orlando, Jeffrey C. Wagner, Christopher V. Fanale, Michelle Whaley, Kathryn L. McCarthy, David Bar-Or Source Type: research
Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients?
The effect of prior antiplatelet (AP) therapy on the risk of hemorrhagic transformation (HT), and on functional outcomes of acute ischemic stroke (AIS) after intravenous thrombolysis (IVT), is not known. We performed a retrospective analysis to determine whether history of AP therapy is associated with post-thrombolysis HT and poor prognosis in AIS patients.
Source: Journal of Stroke and Cerebrovascular Diseases - March 17, 2016 Category: Neurology Authors: Siyan Chen, Xia Lu, Wanli Zhang, Zhao Han, Wen Yang, Xuerong Huang, Xiaoping Jin, Zhimin Wang, Haiyan Liang, Weiwen Qiu, Jianhua Cheng, Bei Shao Source Type: research
Type 2 Diabetes and Hemorrhagic Stroke: A Population-Based Study in Spain from 2003 to 2012
The objective of this study is to compare trends in outcomes for intracerebral hemorrhagic stroke in people with or without type 2 diabetes in Spain between 2003 and 2012.
Source: Journal of Stroke and Cerebrovascular Diseases - March 22, 2016 Category: Neurology Authors: Nuria Muñoz-Rivas, Manuel Méndez-Bailón, Valentín Hernández-Barrera, José Mª de Miguel-Yanes, Rodrigo Jimenez-Garcia, Jesus Esteban-Hernández, Ana Lopez-de-Andrés Source Type: research
Severe Hemorrhagic Transformation after Thrombolysis for Acute Ischemic Stroke Prevents Early Neurological Improvement
This study aims to investigate whether there are any independent associations between different radiological subtypes of HT and the degree of neurological improvement 24 hours after thrombolysis.
Source: Journal of Stroke and Cerebrovascular Diseases - June 14, 2016 Category: Neurology Authors: Dipender Gill, Aravindhan Baheerathan, Adarsh Aravind, Roland Veltkamp, Arindam Kar Source Type: research
